Pharmaceutical compositions comprising of arsenous acid, its sodium salt and its derivatives intended for the treatment of urogenital cancer and its metastasis
Details for Australian Patent Application No. 2006244767 (hide)
International Classifications
Event Publications
29 November 2007 PCT application entered the National Phase
PCT publication WO2006/121280 Priority application(s): WO2006/121280
20 March 2008 Amendment Made
The nature of the amendment is: Amend the name of the inventor to delete co-inventors Yang, Yong-Jin and Lee, Sang-Bong and add Inventor Rademaker, Bernardus.
14 January 2010 Assignment before Grant
Komipharm International Co., Ltd. The application has been assigned to Kominox, Inc.
16 June 2011 Application Accepted
Published as AU-B-2006244767
13 October 2011 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2006244791-Acute leukemia and lymphoblastic lymphoma-specific CD43 epitope and use thereof
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser